284 related articles for article (PubMed ID: 23149937)
1. RBFOX2 is an important regulator of mesenchymal tissue-specific splicing in both normal and cancer tissues.
Venables JP; Brosseau JP; Gadea G; Klinck R; Prinos P; Beaulieu JF; Lapointe E; Durand M; Thibault P; Tremblay K; Rousset F; Tazi J; Abou Elela S; Chabot B
Mol Cell Biol; 2013 Jan; 33(2):396-405. PubMed ID: 23149937
[TBL] [Abstract][Full Text] [Related]
2. The RNA-binding protein Rbfox2: an essential regulator of EMT-driven alternative splicing and a mediator of cellular invasion.
Braeutigam C; Rago L; Rolke A; Waldmeier L; Christofori G; Winter J
Oncogene; 2014 Feb; 33(9):1082-92. PubMed ID: 23435423
[TBL] [Abstract][Full Text] [Related]
3. Alternative microexon splicing by RBFOX2 and PTBP1 is associated with metastasis in colorectal cancer.
Mochizuki Y; Funayama R; Shirota M; Kikukawa Y; Ohira M; Karasawa H; Kobayashi M; Ohnuma S; Unno M; Nakayama K
Int J Cancer; 2021 Nov; 149(10):1787-1800. PubMed ID: 34346508
[TBL] [Abstract][Full Text] [Related]
4. Identification of recurrent regulated alternative splicing events across human solid tumors.
Danan-Gotthold M; Golan-Gerstl R; Eisenberg E; Meir K; Karni R; Levanon EY
Nucleic Acids Res; 2015 May; 43(10):5130-44. PubMed ID: 25908786
[TBL] [Abstract][Full Text] [Related]
5. An EMT-driven alternative splicing program occurs in human breast cancer and modulates cellular phenotype.
Shapiro IM; Cheng AW; Flytzanis NC; Balsamo M; Condeelis JS; Oktay MH; Burge CB; Gertler FB
PLoS Genet; 2011 Aug; 7(8):e1002218. PubMed ID: 21876675
[TBL] [Abstract][Full Text] [Related]
6. Splicing factor ratio as an index of epithelial-mesenchymal transition and tumor aggressiveness in breast cancer.
Fici P; Gallerani G; Morel AP; Mercatali L; Ibrahim T; Scarpi E; Amadori D; Puisieux A; Rigaud M; Fabbri F
Oncotarget; 2017 Jan; 8(2):2423-2436. PubMed ID: 27911856
[TBL] [Abstract][Full Text] [Related]
7. Alternative splicing of the multidrug resistance protein 1/ATP binding cassette transporter subfamily gene in ovarian cancer creates functional splice variants and is associated with increased expression of the splicing factors PTB and SRp20.
He X; Ee PL; Coon JS; Beck WT
Clin Cancer Res; 2004 Jul; 10(14):4652-60. PubMed ID: 15269137
[TBL] [Abstract][Full Text] [Related]
8. An ESRP-regulated splicing programme is abrogated during the epithelial-mesenchymal transition.
Warzecha CC; Jiang P; Amirikian K; Dittmar KA; Lu H; Shen S; Guo W; Xing Y; Carstens RP
EMBO J; 2010 Oct; 29(19):3286-300. PubMed ID: 20711167
[TBL] [Abstract][Full Text] [Related]
9. The long non-coding RNA MALAT1 promotes ovarian cancer progression by regulating RBFOX2-mediated alternative splicing.
Gordon MA; Babbs B; Cochrane DR; Bitler BG; Richer JK
Mol Carcinog; 2019 Feb; 58(2):196-205. PubMed ID: 30294913
[TBL] [Abstract][Full Text] [Related]
10. ERG transcription factors have a splicing regulatory function involving RBFOX2 that is altered in the EWS-FLI1 oncogenic fusion.
Saulnier O; Guedri-Idjouadiene K; Aynaud MM; Chakraborty A; Bruyr J; Pineau J; O'Grady T; Mirabeau O; Grossetête S; Galvan B; Claes M; Al Oula Hassoun Z; Sadacca B; Laud K; Zaïdi S; Surdez D; Baulande S; Rambout X; Tirode F; Dutertre M; Delattre O; Dequiedt F
Nucleic Acids Res; 2021 May; 49(9):5038-5056. PubMed ID: 34009296
[TBL] [Abstract][Full Text] [Related]
11. RBFOX2 protein domains and cellular activities.
Arya AD; Wilson DI; Baralle D; Raponi M
Biochem Soc Trans; 2014 Aug; 42(4):1180-3. PubMed ID: 25110022
[TBL] [Abstract][Full Text] [Related]
12. Alternative splicing induces cytoplasmic localization of RBFOX2 protein in calcific tendinopathy.
Cho N; Kim JO; Lee S; Choi S; Kim J; Ko MS; Park SJ; Ji JH; Kim KK
Exp Mol Pathol; 2019 Aug; 109():36-41. PubMed ID: 31128090
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of activation and repression by the alternative splicing factors RBFOX1/2.
Sun S; Zhang Z; Fregoso O; Krainer AR
RNA; 2012 Feb; 18(2):274-83. PubMed ID: 22184459
[TBL] [Abstract][Full Text] [Related]
14. Tumor microenvironment-associated modifications of alternative splicing.
Brosseau JP; Lucier JF; Nwilati H; Thibault P; Garneau D; Gendron D; Durand M; Couture S; Lapointe E; Prinos P; Klinck R; Perreault JP; Chabot B; Abou-Elela S
RNA; 2014 Feb; 20(2):189-201. PubMed ID: 24335142
[TBL] [Abstract][Full Text] [Related]
15. RBFOX2 promotes protein 4.1R exon 16 selection via U1 snRNP recruitment.
Huang SC; Ou AC; Park J; Yu F; Yu B; Lee A; Yang G; Zhou A; Benz EJ
Mol Cell Biol; 2012 Jan; 32(2):513-26. PubMed ID: 22083953
[TBL] [Abstract][Full Text] [Related]
16. Endothelial, epithelial, and fibroblast cells exhibit specific splicing programs independently of their tissue of origin.
Mallinjoud P; Villemin JP; Mortada H; Polay Espinoza M; Desmet FO; Samaan S; Chautard E; Tranchevent LC; Auboeuf D
Genome Res; 2014 Mar; 24(3):511-21. PubMed ID: 24307554
[TBL] [Abstract][Full Text] [Related]
17. MBNL1 and RBFOX2 cooperate to establish a splicing programme involved in pluripotent stem cell differentiation.
Venables JP; Lapasset L; Gadea G; Fort P; Klinck R; Irimia M; Vignal E; Thibault P; Prinos P; Chabot B; Abou Elela S; Roux P; Lemaitre JM; Tazi J
Nat Commun; 2013; 4():2480. PubMed ID: 24048253
[TBL] [Abstract][Full Text] [Related]
18. Transcriptomic analysis of PNN- and ESRP1-regulated alternative pre-mRNA splicing in human corneal epithelial cells.
Joo JH; Correia GP; Li JL; Lopez MC; Baker HV; Sugrue SP
Invest Ophthalmol Vis Sci; 2013 Jan; 54(1):697-707. PubMed ID: 23299472
[TBL] [Abstract][Full Text] [Related]
19. SAP155-mediated splicing of FUSE-binding protein-interacting repressor serves as a molecular switch for c-myc gene expression.
Matsushita K; Kajiwara T; Tamura M; Satoh M; Tanaka N; Tomonaga T; Matsubara H; Shimada H; Yoshimoto R; Ito A; Kubo S; Natsume T; Levens D; Yoshida M; Nomura F
Mol Cancer Res; 2012 Jun; 10(6):787-99. PubMed ID: 22496461
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive Analysis of Alternative Splicing in Gastric Cancer Identifies Epithelial-Mesenchymal Transition Subtypes Associated with Survival.
Jun Y; Suh YS; Park S; Lee J; Kim JI; Lee S; Lee WP; Anczuków O; Yang HK; Lee C
Cancer Res; 2022 Feb; 82(4):543-555. PubMed ID: 34903603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
